IRWD: Ironwood医药

IRWD新闻

• 11:32 Ironwood Pharmaceuticals Appoints Tammi Gaskins CEO, Effective Jan. 1, 2027
• 13:57 Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?
• 13:08 Ironwood Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript
• 15:08 PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?
• 13:50 Ironwood Pharmaceuticals (IRWD) is a Top-Ranked Momentum Stock: Should You Buy?
• 13:30 5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
• 13:42 Ironwood Stock: Medicare Is Not The Problem I Thought It Was (NASDAQ:IRWD)
• 17:10 Ironwood Pharmaceuticals: High Dependence On Its Next Trial (NASDAQ:IRWD)
• 16:53 Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View Raised
• 13:50 Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates
• 15:36 Community Health Q2 Loss Wider Than Expected, 2026 View Lowered
• 16:15 UnitedHealth Tops Q2 Earnings on Cost Control, Raises '26 Outlook
• 13:50 Here's Why Ironwood Pharmaceuticals (IRWD) is a Strong Momentum Stock
• 21:36 Ironwood: Linzess Buys Time, But Apraglutide's rNPV Doesn't Close The Gap (NASDAQ:IRWD)
• 14:14 BioCryst (BCRX) Surges 8.1%: Is This an Indication of Further Gains?
• 12:25 4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues
• 08:59 Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
• 12:40 5 Small Drug Stocks to Invest in Amid a Biotech Comeback
• 13:38 Can Linzess Continue Driving IRWD's Revenue Growth Through 2026?
• 14:08 IRWD's Linzess Wins FDA Nod for Expanded Pediatric Constipation Use
• 00:17 Ironwood Pharmaceuticals: A Contrarian Buy Opportunity (NASDAQ:IRWD)
• 16:21 Ironwood Pharmaceuticals, Inc: Still A Profitable Opportunity (NASDAQ:IRWD)
• 17:31 Ironwood Stock Down Despite Q1 Earnings and Revenue Beat
• 00:21 Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2026 Earnings Call Transcript